Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), Formulation (Matrix & Gel Hemostats, Sheet & Pad Hemostats, Sponge Hemostats, Powder Hemostats), Application (Orthopedic, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery), Indication (Wound Closure, Surgery), End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), – Industry Trends and Forecast to 2029
Market Analysis and Size
Blood loss occurs during surgery as a result of blood vessel disruption. To avoid excessive blood loss, it is critical to coagulate the blood. Hemostasis refers to the formation of blood clots at the site of injury. Haemostats are surgical tools used to control the patient's bleeding during surgery. These devices aid in the formation of temporary blood clots in order to control bleeding. It is critical, however, that the use of these tools be localised and strictly regulated.
Data Bridge Market Research analyses that the hemostats market is expected to reach the value of USD 4.65 billion by the year 2029, at a CAGR of 6.85% during the forecast period. The hemostats market is being driven by an increase in the number of surgical procedures.
Market Definition
A haemostat is a surgical tool used to control blood loss or stop bleeding during major surgery. Essentially, it is used in the early stages of surgery for an initial incision that closes blood vessels until they are ligated. It includes a variety of instruments such as needle holders, pivots, clamps, and clamps.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), Formulation (Matrix & Gel Hemostats, Sheet & Pad Hemostats, Sponge Hemostats, Powder Hemostats), Application (Orthopedic, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery), Indication (Wound Closure, Surgery), End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (US), Stryker (US), and Integra Lifesciences Corporation(US).
|
Hemostats Market Dynamics
Drivers
- The rise in the surgical procedures
Increasing the number of surgical procedures is a critical factor driving market growth, as is an increase in the number of regulatory approvals, an increase in the incidence of sports-related injuries and spinal ailments, and an increase in the focus on effective blood loss management in patients during surgeries, among other factors driving the hemostats market.
The increase in the research and development activities and growing awareness
Rising R&D activities in the market, an increase in the number of hospitals & surgical centres, and an increase in emerging markets will all create new opportunities for the hemostats market during the forecasted period.
- Government investments for healthcare interoperability
The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the hemostats market.
Restraints/Challenges
The scarcity of skilled professionals and trained expertise will be a major impediment to the growth of the hemostats market. Medication costs will also slow the market's growth rate. Inadequate reimbursement policies will also limit the scope of growth.
This hemostats market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hemostats market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Hemostats Market
With the World Health Organization officially declaring the COVID-19 outbreak a pandemic, a coalition of established pharmaceutical and biopharmaceutical companies, as well as small startups, has stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus. The COVID-19 outbreak has had a significant impact on the availability of hospital resources around the world. This has primarily been addressed by drastically reducing inpatient and outpatient services for other diseases, as well as implementing infection prevention and control measures. With the pandemic affecting countries all over the world, the number of surgical procedures has plummeted precipitously.
Global Hemostats Market Scope
The hemostats market is segmented on the basis product type, formulation, application, indication and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product type
- Combination
- Oxidized regenerated cellulose based
- Gelatine based
- Collagen based haemostat
On the basis of product type, the hemostats market is segmented into thrombin based, combination, oxidized regenerated cellulose based, gelatin based and collagen based hemostat.
Formulation
- Matrix and gel hemostats
- Sheet and pad hemostats
- Sponge hemostats
- Powder hemostats
Based on formulation, the hemostats market is segmented into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats and powder hemostats.
Application
- Orthopaedic
- General surgery
- Neurological surgery
- Cardiovascular surgery
- Reconstructive surgery
- Gynaecological surgery
Based on application, the hemostats market is segmented into orthopedic, general surgery, neurological surgery, cardiovascular surgery, reconstructive surgery and gynecological surgery.
Indication
- Closure
- Surgery
Based on indication, the hemostats market is segmented into wound closure and surgery.
End User
- Ambulatory centers
- Hospitals
- Clinics
- Community healthcare
- Others
The hemostats market is also segmented on the basis of end-user into hospitals, clinics, ambulatory centers, community healthcare and others.
Hemostats Market Regional Analysis/Insights
The hemostats market is analysed and market size insights and trends are provided by country, product type, formulation, application, indication and end-user as referenced above.
The countries covered in the hemostats market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific dominates the hemostats market due to an increase in the number of surgeries performed in the region, as well as the development of technologically advanced products for achieving blood control during trauma-related procedures.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The hemostats market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hemostats market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hemostats market. The data is available for historic period 2010-2020.
Competitive Landscape and Hemostats Market Share Analysis
The hemostats market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to hemostats market.
Some of the major players operating in the hemostats market are
- CR Bard, Inc. (US)
- B. Braun Melsungen AG (Germany)
- Baxter International, Inc. (US)
- Integra LifeSciences (US)
- Marine Polymer Technologies, Inc. (US)
- Teleflex (US)
- Ethicon, Inc. (US)
- Pfizer, Inc. (US)
- Z-Medica LLC (US)
- Gelita Medical GmbH (Germany)
- Anika Therapeutics, Inc. (US)
- Stryker (US)
- Integra Lifesciences Corporation(US).
SKU-